Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,058 headlines found


Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks / A Randomized Clinical Trial

Among adults motivated to quit smoking, 12 weeks of open-label treatment with nicotine patch, varenicline, or C-NRT produced no significant differences in biochemically confirmed rates of smoking abstinence at 26 weeks. The results raise questions about t
Journal of the American Medical Association (JAMA)
added Jan 28, 2016 15:08

No Efficacy Difference for Chantix, Nicotine Replacement

No significant difference was seen in smoking cessation rates at 6-months and a year among smokers treated with nicotine patches alone, a combination nicotine patches and lozenges, or the anti-smoking drug varenicline (Chantix) in a head-to-head comparis
MedPage Today
added Jan 28, 2016 15:07
1 View

No Winners in Patch/Lozenge Combo Study

While varenicline (Chantix) has boasted quit rates higher than the nicotine patch in some prior studies, the drug has not been compared with a combination patch/lozenge strategy, which may offer unique benefits. In this 150-second analysis, MedPage Today
MedPage Today
added Jan 27, 2016 15:56

Smoking cessation pill no better than nicotine patches or lozenges

Smoking cessation pills aren’t any better than nicotine patches or lozenges at helping people successfully quit, a U.S. study suggests. Researchers gave more than 1,000 smokers counseling to help them quit and randomly assigned them to receive three mon
added Jan 27, 2016 00:17

No Clear Winner Seen Among Stop-Smoking Aids in Study

Results of the three approaches did not differ significantly at either six months or a year, the investigators found. At six months, the quit rate was 23 percent for the patch, 24 percent for Chantix, and 27 percent for the combination of patch and lozen
HealthDay [HealthScout]
added Jan 26, 2016 17:48

[Australia] Anti-smoking drug potential link to suicide

An anti-smoking drug has become the focus of forensic scientists in Victoria, as concerns emerge regarding its potential link to suicide. The decision to look into the drug, commercially known as Champix, came directly from Victorian coroner Jacqui Hawk
Neos Kosmos (au)
added Jan 20, 2016 20:54

Smoking Cessation and Nicotine De-addiction Products Market to be Worth US$20.8 bn by 2023: Transparency Market Research

The first line treatment for smoking cessation comprises either nicotine replacement therapy (NRT) products or drug therapy. However, recently people willing to quit smoking are also seen preferring e-cigarettes instead of NRT and drugs. E-cigarettes pro
PR Newswire
added Jan 19, 2016 05:53

[New Zealand] A jab to stop cravings for alcohol, cigarettes and junk food

Scientists from Imperial College London believe using the hormones glucagon-like peptide-1 and ghrelin, which have been proved to stave off hunger pangs, they may be able to control the parts of the brain linked to addiction and stress.
New Zealand Herald (nz)
added Jan 17, 2016 20:39

[Canada] Islanders to have more access to medications with 10 new drugs added to the provincial formulary this month

10 new medications are being added to the provincial drug formulary this month to improve treatment and lower the cost... These drugs will benefit more than 200 patients... Smoking cessation therapy: Champix
Government of Prince Edward Island (ca)
added Jan 17, 2016 03:05

1 in 10 Medicaid Recipients Gets Drugs to Quit Smoking

Under the Affordable Care Act, state Medicaid programs must cover at least... But even if people on Medicaid who smoke want to quit, states don't always help. State Medicaid programs may prevent them from getting anti-smoking drugs through policies such a
HealthDay [HealthScout]
added Jan 7, 2016 02:28
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines